WO2026052111A1 - Poly-arnm - Google Patents

Poly-arnm

Info

Publication number
WO2026052111A1
WO2026052111A1 PCT/CN2025/119781 CN2025119781W WO2026052111A1 WO 2026052111 A1 WO2026052111 A1 WO 2026052111A1 CN 2025119781 W CN2025119781 W CN 2025119781W WO 2026052111 A1 WO2026052111 A1 WO 2026052111A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymrna
mrna
polya
linker
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/CN2025/119781
Other languages
English (en)
Chinese (zh)
Inventor
程永升
李尚阳
吴良营
杨冬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pixel Biosciences Suzhou Co Ltd
Original Assignee
Pixel Biosciences Suzhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pixel Biosciences Suzhou Co Ltd filed Critical Pixel Biosciences Suzhou Co Ltd
Publication of WO2026052111A1 publication Critical patent/WO2026052111A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne un poly-ARNm, comprenant une pluralité de structures d'ARNm. Chaque structure d'ARNm comprend : une région de coiffe à l'extrémité 5' ; et un cadre de lecture ouvert (ORF) codant pour un polypeptide. La pluralité de structures d'ARNm comprend une première structure d'ARNm et une seconde structure d'ARNm. L'extrémité 3' de la première structure d'ARNm est liée de manière covalente à la seconde structure d'ARNm.
PCT/CN2025/119781 2024-09-06 2025-09-08 Poly-arnm Pending WO2026052111A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2024117477 2024-09-06
CNPCT/CN2024/117477 2024-09-06

Publications (1)

Publication Number Publication Date
WO2026052111A1 true WO2026052111A1 (fr) 2026-03-12

Family

ID=99013161

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2025/119781 Pending WO2026052111A1 (fr) 2024-09-06 2025-09-08 Poly-arnm

Country Status (1)

Country Link
WO (1) WO2026052111A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020162A (en) * 1997-06-13 2000-02-01 The Rockefeller University Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof
CN109072223A (zh) * 2016-04-08 2018-12-21 川斯勒佰尔公司 多聚体编码核酸及其用途
CN115960926A (zh) * 2022-12-30 2023-04-14 南方科技大学 一种mRNA及含有mRNA的药物
CN116239642A (zh) * 2023-03-13 2023-06-09 上海兆维科技发展有限公司 加帽聚核苷酸、加帽mRNA及组合物、药物蛋白及制备方法和应用、药物制剂
US20240229109A1 (en) * 2021-04-01 2024-07-11 Modernatx, Inc. Methods for identification and ratio determination of rna species in multivalent rna compositions
US20240294592A1 (en) * 2023-02-16 2024-09-05 Nanjing GeneLeap Biotechnology Co., Ltd. A 5'-CAP ANALOG MODIFIED mRNA

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020162A (en) * 1997-06-13 2000-02-01 The Rockefeller University Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof
CN109072223A (zh) * 2016-04-08 2018-12-21 川斯勒佰尔公司 多聚体编码核酸及其用途
US20240229109A1 (en) * 2021-04-01 2024-07-11 Modernatx, Inc. Methods for identification and ratio determination of rna species in multivalent rna compositions
CN115960926A (zh) * 2022-12-30 2023-04-14 南方科技大学 一种mRNA及含有mRNA的药物
US20240294592A1 (en) * 2023-02-16 2024-09-05 Nanjing GeneLeap Biotechnology Co., Ltd. A 5'-CAP ANALOG MODIFIED mRNA
CN116239642A (zh) * 2023-03-13 2023-06-09 上海兆维科技发展有限公司 加帽聚核苷酸、加帽mRNA及组合物、药物蛋白及制备方法和应用、药物制剂

Similar Documents

Publication Publication Date Title
JP2023552037A (ja) Rna編集のための人工核酸
EP4337331A1 (fr) Arnm modifié, arn non codant modifié, et leurs utilisations
CA3129660A1 (fr) Oligonucleotides antisens d'edition d'acide nucleique
AU7406700A (en) Design of high affinity rnase h recruiting oligonucleotide
KR20260006688A (ko) 폴리 테일 및 폴리 캡 mRNA 그리고 그의 용도
WO2020061397A1 (fr) Compositions et procédés d'administration d'acides nucléiques
JP2024521304A (ja) 環状ポリリボヌクレオチドを濃縮する方法
Danielsen et al. Cationic oligonucleotide derivatives and conjugates: A favorable approach for enhanced DNA and RNA targeting oligonucleotides
WO2024002269A1 (fr) Molécule de ciblage d'arnm médiée par une protéine, son procédé de préparation et son utilisation
CN111197070A (zh) 鉴定rna分子中2`-o-甲基化修饰的方法及其应用
CN117448322A (zh) 一种靶向AGT基因表达的siRNA
WO2026052111A1 (fr) Poly-arnm
JP2024523054A (ja) 環状ポリリボヌクレオチドを濃縮する方法
CN121057820A (zh) 使用环状前药核酸递送rna治疗药物
CN121344095B (zh) 一种细胞内mRNA传感器开关的DNA文库筛选方法及应用
WO2025180432A1 (fr) Enzyme pour coiffage d'arn et son système de réaction
CN120905229B (zh) 一种靶向INHBE基因表达的siRNA及其缀合物和用途
WO2025087417A1 (fr) Outil efficace d'édition de gène à faibles effets hors-cible
WO2025250382A1 (fr) Procédé et compositions pour l'administration d'agents thérapeutiques médiée par des aptamères
WO2025073902A1 (fr) Optimisation chimique et de séquence d'oligonucléotides antisens pour édition d'arn médiée par adar
CN121344095A (zh) 一种细胞内mRNA传感器开关的DNA文库筛选方法及应用
WO2025040097A1 (fr) Arnsi ciblant angptl4, conjugué et utilisation associée
TW202545538A (zh) 新型誘導類細胞質體外轉錄組成物及其相關疫苗藥物設計
WO2026079489A1 (fr) Composition, médicament, procédé de production de composition et procédé d'introduction intracellulaire d'une molécule d'arn
CN121087040A (zh) 一种用于高通量筛选rna递送系统的方法及其应用